trial
phase
male
holstein
calv
initi
age
transport
h
research
facil
calv
randomli
select
either
receiv
sc
inject
zuprevo
merck
anim
health
summit
nj
mg
tildipirosinkg
bw
til
day
arriv
wean
receiv
inject
con
calv
fed
kg
milk
replac
dm
daili
kg
daili
starter
fed
free
choic
phase
trial
phase
calv
phase
group
con
til
move
group
pen
pen
per
treatment
calv
per
pen
next
starter
blend
chop
grass
hay
fed
free
choic
trial
similar
trial
phase
use
twomonthold
male
holstein
calv
calv
randomli
select
receiv
either
sc
inject
zuprevo
mg
tildipirosinkg
bw
til
inject
con
trial
phase
prewean
adg
bc
chang
postwean
starter
intak
hip
width
chang
overal
starter
intak
adg
hip
width
chang
final
hip
width
final
bc
greater
til
con
phase
trial
trial
calf
adg
hip
width
chang
greater
til
con
overal
transport
holstein
calv
til
improv
adg
structur
growth
approxim
respiratori
infect
signific
concern
dairi
calv
mo
age
svensson
et
al
primari
caus
mortal
wean
usdaaphi
stanton
et
al
report
improv
calf
growth
metaphylact
treatment
rel
healthi
calv
tulathromycin
tul
stanton
et
al
stanton
et
al
stanton
et
al
also
report
metaphylact
use
tul
commingl
dairi
calv
reduc
incid
diarrhea
otiti
media
bovin
respiratori
diseas
complex
compar
either
metaphylact
treatment
oxytetracyclin
antibiot
treatment
tildipirosin
til
antibiot
approv
control
respiratori
diseas
cattl
high
risk
develop
bovin
respiratori
diseas
may
remain
lung
tissu
meng
et
al
tulathromycin
til
report
good
efficaci
reduc
issu
respiratori
pathogen
dairi
calv
less
mo
age
amrin
et
al
confer
et
al
bartram
et
al
amrin
et
al
bartram
et
al
report
calf
adg
mannheimia
haemolytica
mycoplasma
bovi
challeng
greater
calv
treat
til
tul
compar
nonantibiotictr
calv
although
govern
agenc
encourag
less
use
antibiot
livestock
wees
et
al
proper
metaphylact
use
antibiot
livestock
might
lower
overal
use
antibiot
reduc
risk
antibiot
resist
wees
addit
metaphylact
antibiot
treatment
dairi
calv
implement
mani
farm
usdaaphi
therefor
success
use
tul
til
reduc
respiratori
sick
common
preand
postwean
dairi
calv
improv
growth
calv
treat
tul
studi
research
implement
test
metaphylact
use
til
preand
postwean
dairi
calv
calv
care
accept
practic
describ
guid
care
use
agricultur
anim
agricultur
research
teach
fass
phase
trial
male
holstein
calv
initi
age
singl
dairi
farm
transport
h
nurtur
research
center
southwest
ohio
upon
arriv
calv
randomli
select
either
receiv
sc
inject
zuprevo
merck
anim
health
summit
nj
mg
tildipirosinkg
bw
til
day
arriv
wean
receiv
inject
con
calv
hous
individu
pen
coars
rock
tiledrain
floor
bed
straw
curtainsid
natur
ventil
barn
ad
heat
milk
replac
fed
kg
dm
daili
kg
dm
daili
milk
replac
manufactur
whey
whey
protein
concentr
anim
fat
cp
fat
tabl
reconstitut
solid
warm
water
fed
h
daili
lowstarch
pellet
starter
similar
one
fed
hill
et
al
water
fed
free
choic
phase
everi
bag
milk
replac
starter
sampl
composit
nutrient
analysi
tabl
manag
practic
includ
vaccin
medic
treatment
trial
base
recommend
herd
veterinarian
day
arriv
approxim
noon
calv
weigh
initi
bw
time
blood
sampl
intraven
serum
separ
centrifug
g
vwr
batavia
il
min
serum
protein
concentr
estim
use
optic
refractomet
atago
usa
inc
bellevu
wa
fece
score
daili
use
scale
normal
wateri
modifi
kertz
chesterjon
calv
fecal
score
greater
consid
abnorm
fecal
score
receiv
oral
electrolyt
count
medic
treatment
first
first
abnorm
fece
fecal
score
greater
per
calf
sampl
mix
aliquot
test
cryptosporidium
rotaviru
coronaviru
escherichia
coli
use
later
immunochromatographi
strip
biox
diagnost
jemel
belgium
antibiot
medic
treatment
record
daili
baytril
bayer
healthcar
shawne
mission
ks
ml
subcutan
administ
cough
nasal
discharg
labor
breath
rectal
temperatur
navel
infect
treat
ml
penicillin
g
procain
unitsml
agri
laboratori
ltd
st
joseph
mo
intramuscularli
daili
experienc
technician
use
stethoscop
listen
abnorm
sound
associ
breath
right
anterior
side
calf
assist
identif
respiratori
diseas
calv
receiv
intranas
tissu
sensit
respiratori
diseas
vaccin
zoeti
exton
pa
sc
inject
vitamin
e
vital
e
stuart
product
bedford
tx
se
muse
merck
anim
health
upon
arriv
calv
receiv
inject
bovashield
gold
zoeti
calv
castrat
dehorn
age
calv
weigh
initi
weekli
thereaft
bodi
condit
score
thin
obes
modifi
wildman
et
al
hip
width
use
calip
measur
initi
everi
wk
thereaft
phase
trial
calv
phase
group
con
til
move
group
pen
pen
per
treatment
calv
per
pen
next
pen
outsid
pen
space
insid
pen
space
per
calf
insid
pen
space
bed
straw
ad
heat
starter
fed
phase
blend
chop
grass
hay
tabl
fed
water
free
choic
everi
bag
starter
everi
bale
hay
sampl
composit
nutrient
analysi
calv
weigh
score
bodi
condit
measur
hip
width
initi
phase
averag
ambient
temperatur
trial
phase
rang
averag
rel
humid
rang
averag
ambient
temperatur
trial
phase
rang
averag
rel
humid
rang
trial
length
holstein
calv
mo
age
kg
bw
randomli
select
either
receiv
sc
inject
tildipirosin
til
zuprevo
merck
anim
health
mgkg
bw
receiv
inject
con
calv
previous
transport
h
manag
phase
trial
calv
wean
wk
trial
began
feed
tabl
averag
ambient
temperatur
trial
rang
averag
rel
humid
rang
composit
feed
refus
feed
fece
analyz
describ
hill
et
al
nutrient
analysi
refus
feed
wk
pen
resembl
feed
offer
phase
trial
data
first
group
wk
except
hip
width
bc
chang
group
period
data
analyz
complet
random
design
repeat
measur
applic
proc
mix
sa
version
sa
institut
inc
cari
nc
autoregress
type
covari
matrix
employ
determin
use
akaik
inform
criteria
except
abnorm
fecal
score
day
medic
day
sum
entir
phase
analyz
use
kruskalw
test
proc
sa
calf
one
calf
per
pen
experiment
unit
phase
trial
trial
intak
growth
data
analyz
complet
random
design
repeat
measur
applic
group
two
segment
bodi
measur
proc
mix
sa
autoregress
type
covari
matrix
employ
determin
use
akaik
inform
criteria
pen
experiment
unit
signific
determin
p
initi
measur
differ
phase
trial
tabl
prewean
adg
vs
kgd
bc
chang
greater
p
til
con
tabl
postwean
starter
intak
vs
kgd
hip
width
chang
vs
cm
greater
p
til
con
overal
starter
intak
adg
vs
kgd
hip
width
chang
vs
cm
final
hip
width
final
bc
greater
p
til
con
number
medic
treatment
differ
treatment
con
calv
treat
navel
infect
calv
treat
nasal
discharg
calv
retreat
day
later
fever
prewean
period
postwean
period
addit
calf
treat
nasal
discharg
til
calv
treat
navel
infect
calv
treat
nasal
discharg
one
calv
treat
nasal
discharg
treat
day
later
fever
navel
infect
identifi
treatment
began
abnorm
breath
sound
detect
use
stethoscop
abnorm
fecal
score
differ
treatment
fece
calv
abnorm
fece
test
posit
cryptosporidium
rotaviru
organ
phase
trial
calf
adg
vs
kgd
hip
width
chang
vs
cm
final
hip
width
final
bc
greater
p
til
con
tabl
phase
overal
increas
bw
hip
width
gain
treat
til
greater
compar
con
phase
overal
increas
bw
hip
width
gain
treat
til
greater
compar
con
phase
til
calv
gain
kg
bw
vs
kg
gain
cm
hip
width
vs
cm
con
calv
trial
initi
measur
differ
tabl
calv
treat
sick
trial
calf
adg
vs
kgd
feed
effici
vs
g
f
hip
width
chang
vs
cm
greater
p
calv
treat
til
con
tabl
trial
til
calv
gain
kg
bw
cm
hip
width
con
calv
virus
allow
bacteri
colon
lung
typic
reason
onset
respiratori
diseas
beef
calv
yate
stressor
trigger
diseas
calv
effect
cortisol
variou
cytokin
hulbert
stressor
present
major
day
first
mo
dairi
calf
life
hulbert
calv
current
trial
face
mani
stressor
includ
transport
birth
farm
research
facil
sever
vaccin
castrat
dehorn
wean
commingl
expect
treat
calv
respiratori
diseas
base
treatment
rate
group
calv
research
facil
prior
year
specul
level
respiratori
diseas
calv
identifi
treat
use
til
may
reduc
incid
subclin
respiratori
diseas
allow
increas
growth
calv
current
trial
appear
rel
healthi
base
ill
identifi
trial
phase
calv
treat
type
nasal
discharg
fever
appear
relat
respiratori
infect
navel
infect
calv
evenli
distribut
con
til
calv
six
calv
navel
infect
iodinestain
hair
around
navel
wherea
calv
without
navel
infect
show
stain
thu
sourcefarm
personnel
may
properli
dip
navel
iodin
solut
birth
calv
treat
sick
phase
trial
amrin
et
al
report
adg
feeder
calv
kg
bw
mannheimia
haemolytica
challeng
increas
calv
treat
til
tul
compar
nonantibiotictr
calv
bartram
et
al
report
adg
dairi
calv
mycoplasma
bovi
challeng
increas
treat
til
tul
compar
nonantibiotictr
calv
studi
mani
calv
sick
diseas
caus
challeng
organ
stanton
et
al
hill
et
al
report
improv
calf
growth
metaphylact
treatment
rel
healthi
calv
tul
stanton
et
al
stanton
et
al
stanton
et
al
also
report
metaphylact
use
tul
commingl
dairi
calv
lower
incid
diarrhea
otiti
media
bovin
respiratori
diseas
complex
compar
either
metaphylact
treatment
oxytetracyclin
antibiot
treatment
howev
growth
chang
use
tul
calv
sick
attribut
improv
growth
reduct
diseas
calv
trial
calv
treat
til
gain
approxim
bw
hip
width
con
mo
age
similar
design
rel
healthi
dairi
calv
treatment
tul
increas
bw
hip
width
gain
approxim
compar
tabl
perform
calv
treat
con
treat
til
zuprevo
mg
tildipirosinkg
bw
near
birth
wean
apart
trial
phase
feed
effici
calcul
gain
divid
sum
milk
replac
starter
intak
fece
score
daili
use
scale
normal
wateri
day
fecal
score
greater
con
mo
age
hill
et
al
trial
stanton
et
al
stanton
et
al
healthi
calv
experienc
improv
bw
structur
growth
first
mo
age
metaphylact
administ
tul
growth
experienc
first
mo
life
appear
maintain
approxim
yr
age
studi
stanton
et
al
calv
appear
healthi
medic
treatment
con
calv
low
number
medic
treatment
diseas
affect
til
improv
bw
structur
growth
realiz
metaphylact
treatment
dairi
calv
tildipirosin
mgkg
bw
result
approxim
bw
hip
width
gain
transport
holstein
calv
mo
age
gener
calv
trial
healthi
calv
treat
respiratori
enter
diseas
research
fulli
fund
provimi
brookvil
oh
tabl
perform
calv
mo
age
data
treat
con
treat
til
zuprevo
mg
tildipirosinkg
bw
trial
phase
trial
trial
calv
zuprevo
administ
calv
wean
bc
system
thin
obes
modifi
wildman
et
al
feed
effici
calcul
gain
divid
dmi
